HEADER TRANSCRIPTION 16-SEP-15 5APH TITLE LIGAND COMPLEX OF RORG LBD COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, UNP RESIDUES 265-507; COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 6 GROUP F MEMBER 3, RAR-RELATED ORPHAN RECEPTOR C, RETINOID-RELATED COMPND 7 ORPHAN RECEPTOR-GAMMA, RORG; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 11 CHAIN: C; COMPND 12 FRAGMENT: UNP RESIDUES 686-697; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSCRIPTION, RORG LIGAND, RORG AGONIST, STRUCTURE-BASED DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE,A.AAGAARD,F.NARJES REVDAT 4 10-JAN-24 5APH 1 REMARK REVDAT 3 14-FEB-18 5APH 1 JRNL REVDAT 2 03-FEB-16 5APH 1 JRNL REVDAT 1 25-NOV-15 5APH 0 JRNL AUTH R.I.OLSSON,Y.XUE,S.VON BERG,A.AAGAARD,J.MCPHEAT,E.L.HANSSON, JRNL AUTH 2 J.BERNSTROM,P.HANSSON,J.JIRHOLT,H.GRINDEBACKE,A.LEFFLER, JRNL AUTH 3 R.CHEN,Y.XIONG,H.GE,T.G.HANSSON,F.NARJES JRNL TITL BENZOXAZEPINES ACHIEVE POTENT SUPPRESSION OF IL-17 RELEASE JRNL TITL 2 IN HUMAN T-HELPER 17 (TH 17) CELLS THROUGH AN INDUCED-FIT JRNL TITL 3 BINDING MODE TO THE NUCLEAR RECEPTOR ROR GAMMA. JRNL REF CHEMMEDCHEM V. 11 207 2016 JRNL REFN ESSN 1860-7187 JRNL PMID 26553345 JRNL DOI 10.1002/CMDC.201500432 REMARK 2 REMARK 2 RESOLUTION. 1.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.0 REMARK 3 NUMBER OF REFLECTIONS : 43827 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2193 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.54 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.58 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.98 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2111 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2650 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2003 REMARK 3 BIN R VALUE (WORKING SET) : 0.2638 REMARK 3 BIN FREE R VALUE : 0.2903 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.12 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 108 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2159 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 297 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.06 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.95810 REMARK 3 B22 (A**2) : -2.95810 REMARK 3 B33 (A**2) : 5.91620 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.210 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.097 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.095 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.091 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.091 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.924 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2264 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3051 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 811 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 53 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 338 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2264 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 273 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2895 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.94 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.00 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.98 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5APH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1290065060. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43870 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.540 REMARK 200 RESOLUTION RANGE LOW (A) : 48.820 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 12.70 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.54 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 65.8 REMARK 200 DATA REDUNDANCY IN SHELL : 10.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3L0L REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.50000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 30.92500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 30.92500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.75000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 30.92500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 30.92500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 119.25000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 30.92500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 30.92500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 39.75000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 30.92500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 30.92500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 119.25000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 79.50000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 244 REMARK 465 ASN A 245 REMARK 465 HIS A 246 REMARK 465 ASN A 247 REMARK 465 HIS A 248 REMARK 465 ASN A 249 REMARK 465 HIS A 250 REMARK 465 ASN A 251 REMARK 465 HIS A 252 REMARK 465 ASN A 253 REMARK 465 HIS A 254 REMARK 465 ASN A 255 REMARK 465 GLY A 256 REMARK 465 GLY A 257 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 286 -56.26 72.58 REMARK 500 CYS A 393 56.38 -141.47 REMARK 500 GLU A 435 60.96 -103.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2113 DISTANCE = 6.63 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 N-(2-FLUOROPHENYL)-4-[(4-FLUOROPHENYL)SULFONYL]-2,3,4, REMARK 600 5-TETRAHYDRO-1,4-BENZOXAZEPIN-6-AMINE (VYI): COMPOUND REMARK 600 STRCTURE IN THE ATTACHED PICTURE FILE REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VYI A 1510 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 1511 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5APJ RELATED DB: PDB REMARK 900 LIGAND COMPLEX OF RORG LBD REMARK 900 RELATED ID: 5APK RELATED DB: PDB REMARK 900 LIGAND COMPLEX OF RORG LBD DBREF 5APH A 265 507 UNP P51449 RORG_HUMAN 265 507 DBREF 5APH C 686 697 UNP E7EWM1 E7EWM1_HUMAN 686 697 SEQADV 5APH HIS A 244 UNP P51449 EXPRESSION TAG SEQADV 5APH ASN A 245 UNP P51449 EXPRESSION TAG SEQADV 5APH HIS A 246 UNP P51449 EXPRESSION TAG SEQADV 5APH ASN A 247 UNP P51449 EXPRESSION TAG SEQADV 5APH HIS A 248 UNP P51449 EXPRESSION TAG SEQADV 5APH ASN A 249 UNP P51449 EXPRESSION TAG SEQADV 5APH HIS A 250 UNP P51449 EXPRESSION TAG SEQADV 5APH ASN A 251 UNP P51449 EXPRESSION TAG SEQADV 5APH HIS A 252 UNP P51449 EXPRESSION TAG SEQADV 5APH ASN A 253 UNP P51449 EXPRESSION TAG SEQADV 5APH HIS A 254 UNP P51449 EXPRESSION TAG SEQADV 5APH ASN A 255 UNP P51449 EXPRESSION TAG SEQADV 5APH GLY A 256 UNP P51449 EXPRESSION TAG SEQADV 5APH GLY A 257 UNP P51449 EXPRESSION TAG SEQADV 5APH GLU A 258 UNP P51449 EXPRESSION TAG SEQADV 5APH ASN A 259 UNP P51449 EXPRESSION TAG SEQADV 5APH LEU A 260 UNP P51449 EXPRESSION TAG SEQADV 5APH TYR A 261 UNP P51449 EXPRESSION TAG SEQADV 5APH PHE A 262 UNP P51449 EXPRESSION TAG SEQADV 5APH GLN A 263 UNP P51449 EXPRESSION TAG SEQADV 5APH GLY A 264 UNP P51449 EXPRESSION TAG SEQADV 5APH GLY A 508 UNP P51449 EXPRESSION TAG SEQADV 5APH GLY A 509 UNP P51449 EXPRESSION TAG SEQRES 1 A 266 HIS ASN HIS ASN HIS ASN HIS ASN HIS ASN HIS ASN GLY SEQRES 2 A 266 GLY GLU ASN LEU TYR PHE GLN GLY ALA SER LEU THR GLU SEQRES 3 A 266 ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR ARG SEQRES 4 A 266 GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN SEQRES 5 A 266 ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR SEQRES 6 A 266 GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA SEQRES 7 A 266 HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE SEQRES 8 A 266 ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN ASN SEQRES 9 A 266 ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL SEQRES 10 A 266 VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN SEQRES 11 A 266 ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU SEQRES 12 A 266 LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER SEQRES 13 A 266 ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SEQRES 14 A 266 SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU SEQRES 15 A 266 ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS SEQRES 16 A 266 VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS SEQRES 17 A 266 HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA SEQRES 18 A 266 LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER SEQRES 19 A 266 GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS SEQRES 20 A 266 PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS SEQRES 21 A 266 GLU LEU PHE SER GLY GLY SEQRES 1 C 12 LYS HIS LYS ILE LEU HIS ARG LEU LEU GLN ASP SER HET VYI A1510 29 HET DMS A1511 4 HETNAM VYI N-(2-FLUOROPHENYL)-4-[(4-FLUOROPHENYL)SULFONYL]-2,3,4, HETNAM 2 VYI 5-TETRAHYDRO-1,4-BENZOXAZEPIN-6-AMINE HETNAM DMS DIMETHYL SULFOXIDE FORMUL 3 VYI C21 H18 F2 N2 O3 S FORMUL 4 DMS C2 H6 O S FORMUL 5 HOH *297(H2 O) HELIX 1 1 ASN A 259 GLN A 263 5 5 HELIX 2 2 SER A 266 GLU A 283 1 18 HELIX 3 3 ARG A 288 GLN A 295 1 8 HELIX 4 4 ARG A 296 ASN A 298 5 3 HELIX 5 5 SER A 301 LYS A 311 1 11 HELIX 6 6 SER A 312 LEU A 338 1 27 HELIX 7 7 GLY A 340 LEU A 344 5 5 HELIX 8 8 CYS A 345 MET A 365 1 21 HELIX 9 9 GLY A 384 GLY A 392 5 9 HELIX 10 10 CYS A 393 ALA A 409 1 17 HELIX 11 11 SER A 413 ILE A 426 1 14 HELIX 12 12 GLU A 435 THR A 457 1 23 HELIX 13 13 ARG A 459 LEU A 466 5 8 HELIX 14 14 PRO A 468 HIS A 490 1 23 HELIX 15 15 HIS A 490 PHE A 498 1 9 HELIX 16 16 PRO A 499 SER A 507 1 9 HELIX 17 17 ILE C 689 ASP C 696 1 8 SHEET 1 AA 3 TYR A 369 ASN A 370 0 SHEET 2 AA 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SITE 1 AC1 13 TRP A 317 CYS A 320 ALA A 321 HIS A 323 SITE 2 AC1 13 LEU A 324 MET A 358 VAL A 361 MET A 365 SITE 3 AC1 13 PHE A 378 ILE A 400 PHE A 401 TYR A 502 SITE 4 AC1 13 DMS A1511 SITE 1 AC2 4 HIS A 323 PHE A 377 GLU A 379 VYI A1510 CRYST1 61.850 61.850 159.000 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016168 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016168 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006289 0.00000